BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24507753)

  • 1. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
    Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
    Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
    BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.
    Martini G; Cabrelle A; Calabrese F; Carraro S; Scquizzato E; Teramo A; Facco M; Zulian F; Agostini C
    Clin Immunol; 2008 Nov; 129(2):268-76. PubMed ID: 18760678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
    Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
    Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
    Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
    Huang Y; Li DJ; Wang MY; Cheng HD
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
    Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
    Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
    Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
    Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
    Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.